Temat: "Induction Chemotherapy" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Pretreatment MRI-Derived Radiomics May Evaluate the Response of Different Induction Chemotherapy Regimens in Locally advanced Nasopharyngeal Carcinoma.
Autorzy :: Zhang L; Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, China; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China; Department of Radiology, Cancer Hospital of the University of Chinese Academy of Sciences, China.
Ye Z; Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, China; Department of Radiotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China; Department of Radiology, Cancer Hospital of the University of Chinese Academy of Sciences, China.
Ruan L; Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, China; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China; Department of Radiology, Cancer Hospital of the University of Chinese Academy of Sciences, China.
Jiang M; Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, China; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China; Department of Radiology, Cancer Hospital of the University of Chinese Academy of Sciences, China. Electronic address: .; Pokaż więcej
Źródło :: Academic radiology [Acad Radiol] 2020 Dec; Vol. 27 (12), pp. 1655-1664. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :: Journal Article
MeSH Terms :: Induction Chemotherapy*
Nasopharyngeal Neoplasms*/diagnostic imaging
Nasopharyngeal Neoplasms*/drug therapy
Humans ; Magnetic Resonance Imaging ; Nasopharyngeal Carcinoma/diagnostic imaging ; Nasopharyngeal Carcinoma/drug therapy ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma.
Autorzy :: Barrington SF; King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK. Electronic address: .
Trotman J; Haematology Department, Concord Repatriation General, Hospital, University of Sydney, Sydney, NSW, Australia.; Pokaż więcej
Źródło :: The Lancet. Haematology [Lancet Haematol] 2021 Jan; Vol. 8 (1), pp. e80-e93. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Induction Chemotherapy*
Lymphoma, Follicular*/diagnostic imaging
Lymphoma, Follicular*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/diagnostic imaging
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, T-Cell, Peripheral*/diagnostic imaging
Lymphoma, T-Cell, Peripheral*/drug therapy
Positron-Emission Tomography*
Fluorodeoxyglucose F18/*therapeutic use
Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Consensus statement on the treatment of transplant-eligible patients with newly diagnosed multiple myeloma in New Zealand.
Autorzy :: Chien N; Department of Haematology, Auckland City Hospital, Auckland, New Zealand.
Romeril K; Myeloma New Zealand, New Zealand.
Baker B; Department of Haematology, Palmerston North Hospital, Palmerston North, New Zealand.
Goodman H; Department of Haematology, Waikato Hospital, Hamilton, New Zealand.
Chan H; Department of Haematology, Waitemata District Health Board, Auckland, New Zealand.; Pokaż więcej
Źródło :: The New Zealand medical journal [N Z Med J] 2020 Dec 18; Vol. 133 (1527), pp. 104-110. Date of Electronic Publication: 2020 Dec 18.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Bone Marrow Transplantation*/methods
Consolidation Chemotherapy*/methods
Induction Chemotherapy*/methods
Maintenance Chemotherapy*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*therapy
Bortezomib/administration & dosage ; Consensus ; Cyclophosphamide/administration & dosage ; Dexamethasone/administration & dosage ; Lenalidomide ; New Zealand ; Practice Guidelines as Topic ; Thalidomide/administration & dosage
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Classification of three prognostically different groups of Head and Neck Cancer patients based on their metabolic response to induction chemotherapy (IC-1).
Autorzy :: Singh A; Department of Otolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India. Electronic address: .
Singh CA; Department of Otolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
Sikka K; Department of Otolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.; Pokaż więcej
Źródło :: Oral oncology [Oral Oncol] 2020 Dec; Vol. 111, pp. 104936. Date of Electronic Publication: 2020 Aug 22.
Typ publikacji :: Letter; Comment
MeSH Terms :: Head and Neck Neoplasms*/drug therapy
Induction Chemotherapy*
Humans ; Squamous Cell Carcinoma of Head and Neck
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy.
Autorzy :: Ballo O; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany. .
Kreisel EM; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany.
Eladly F; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany.
Brunnberg U; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany.
Stratmann J; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany.
Hunyady P; Department of Medicine, Gastroenterology, Hepatology and Endocrinology, University Hospital, Goethe University, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.
Hogardt M; Institute of Medical Microbiology and Infection Control, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.; University Center for Infectious Diseases, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.; University Center of Competence for Infection Control, Frankfurt - Giessen -, Marburg, Hessen, Germany.
Wichelhaus TA; Institute of Medical Microbiology and Infection Control, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.; University Center for Infectious Diseases, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.; University Center of Competence for Infection Control, Frankfurt - Giessen -, Marburg, Hessen, Germany.
Kempf VAJ; Institute of Medical Microbiology and Infection Control, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.; University Center for Infectious Diseases, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.; University Center of Competence for Infection Control, Frankfurt - Giessen -, Marburg, Hessen, Germany.
Steffen B; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Vehreschild JJ; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany.
Vehreschild MJGT; University Center for Infectious Diseases, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.
Finkelmeier F; Department of Medicine, Gastroenterology, Hepatology and Endocrinology, University Hospital, Goethe University, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.; Frankfurt Cancer Institute, Goethe University Frankfurt, Theodor-Stern-Kai 7, Frankfurt/Main, Germany.
Serve H; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Brandts CH; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Theodor-Stern-Kai 7, 60596, Frankfurt/Main, Germany. .; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. .; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University, Theodor-Stern-Kai 7, Frankfurt/Main, Germany. .; Pokaż więcej
Źródło :: Annals of hematology [Ann Hematol] 2020 Nov; Vol. 99 (11), pp. 2547-2553. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :: Clinical Trial; Journal Article
MeSH Terms :: Clostridioides difficile*
Induction Chemotherapy*
Length of Stay*
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/epidemiology
Leukemia, Myeloid, Acute*/microbiology
Carbapenems/*administration & dosage
Glycopeptides/*administration & dosage
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Enterocolitis, Pseudomembranous/drug therapy ; Enterocolitis, Pseudomembranous/epidemiology ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Major Pathologic Response after Induction Therapy Has a Long-Term Impact on Survival and Tumor Recurrence in Stage IIIA/B Locally Advanced NSCLC.
Autorzy :: Schreiner W; Division of Thoracic Surgery, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
Dudek W; Division of Thoracic Surgery, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
Rieker RJ; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
Lettmaier S; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
Fietkau R; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.
Sirbu H; Division of Thoracic Surgery, Friedrich-Alexander-Universität Erlangen-Nuremberg, Erlangen, Germany.; Pokaż więcej
Źródło :: The Thoracic and cardiovascular surgeon [Thorac Cardiovasc Surg] 2020 Oct; Vol. 68 (7), pp. 639-645. Date of Electronic Publication: 2019 Feb 26.
Typ publikacji :: Journal Article
MeSH Terms :: Chemoradiotherapy, Adjuvant*/adverse effects
Chemoradiotherapy, Adjuvant*/mortality
Induction Chemotherapy*/adverse effects
Induction Chemotherapy*/mortality
Neoadjuvant Therapy*/adverse effects
Neoadjuvant Therapy*/mortality
Neoplasm Recurrence, Local*
Pneumonectomy*/adverse effects
Pneumonectomy*/mortality
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Aged ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Progression-Free Survival ; Retrospective Studies ; Risk Factors ; Time Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Hyperglycemia requiring insulin during acute lymphoblastic leukemia induction chemotherapy is associated with increased adverse outcomes and healthcare costs.
Autorzy :: McCormick MC; Hematology-Oncology, Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Sharp E; Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Kalpatthi R; Hematology-Oncology, Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Zullo J; Clinical Informatics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Gurtunca N; Endocrinology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Zhang J; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Krafty R; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Raman S; Endocrinology, Riley Children's Hospital, Lehigh Valley Health Network, Allentown, Pennsylvania.; Pokaż więcej
Źródło :: Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Sep; Vol. 67 (9), pp. e28475. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Hyperglycemia*/chemically induced
Hyperglycemia*/drug therapy
Hyperglycemia*/economics
Induction Chemotherapy*/adverse effects
Induction Chemotherapy*/economics
Insulin*/administration & dosage
Insulin*/economics
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/economics
Adolescent ; Adult ; Child ; Child, Preschool ; Costs and Cost Analysis ; Female ; Humans ; Infant ; Male
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Modeling Resistance and Recurrence Patterns of Combined Targeted-Chemoradiotherapy Predicts Benefit of Shorter Induction Period.
Autorzy :: McClatchy DM; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. .
Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Hata AN; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.
Piotrowska Z; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.
Sequist LV; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts.
Paganetti H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Grassberger C; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. .; Pokaż więcej
Źródło :: Cancer research [Cancer Res] 2020 Nov 15; Vol. 80 (22), pp. 5121-5133. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Drug Resistance, Neoplasm*
Neoplasm Recurrence, Local*
Carcinoma, Non-Small-Cell Lung/*drug therapy
Chemoradiotherapy/*methods
Induction Chemotherapy/*methods
Lung Neoplasms/*drug therapy
Protein Kinase Inhibitors/*administration & dosage
Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/therapy ; Cell Proliferation ; Clinical Trials as Topic ; Disease Progression ; ErbB Receptors/genetics ; Humans ; Induction Chemotherapy/adverse effects ; Kaplan-Meier Estimate ; Lung Neoplasms/genetics ; Lung Neoplasms/therapy ; Models, Theoretical ; Molecular Targeted Therapy/methods ; Progression-Free Survival ; Protein Kinase Inhibitors/pharmacology ; Radiobiology ; Research Design ; Time Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia.
Autorzy :: Ramos-Peñafiel C; Servicio de Hematología, Hospital General de México, 'Dr. Eduardo Liceaga', 06726, Ciudad de México, Mexico.
Olarte-Carrillo I; Laboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, 'Dr. Eduardo Liceaga', Ciudad de México, Mexico.
Maldonado RC; Laboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, 'Dr. Eduardo Liceaga', Ciudad de México, Mexico.
de la Cruz Rosas A; Laboratorio de Biología Molecular, Servicio de Hematología, Hospital General de México, 'Dr. Eduardo Liceaga', Ciudad de México, Mexico.
Collazo-Jaloma J; Servicio de Hematología, Hospital General de México, 'Dr. Eduardo Liceaga', 06726, Ciudad de México, Mexico.
Martínez-Tovar A; Servicio de Hematología, Hospital General de México, 'Dr. Eduardo Liceaga', 06726, Ciudad de México, Mexico. .; Pokaż więcej
Źródło :: Annals of hematology [Ann Hematol] 2020 Nov; Vol. 99 (11), pp. 2629-2637. Date of Electronic Publication: 2020 Sep 27.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Induction Chemotherapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/mortality
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Gene Expression Regulation, Leukemic/*drug effects
Neoplasm Proteins/*biosynthesis
ATP Binding Cassette Transporter, Subfamily B/biosynthesis ; Adolescent ; Adult ; Aged ; Daunorubicin/administration & dosage ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Prednisolone/administration & dosage ; Retrospective Studies ; Survival Rate ; Time Factors ; Vincristine/administration & dosage
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Venous thromboembolism in non-small cell lung cancer patients who underwent surgery after induction therapy.
Autorzy :: Kaminuma Y; Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, 3453, Mikatahara-Cho, Kita-Ku, Hamamatsu, Shizuoka, 433-8558, Japan. .
Tanahashi M; Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, 3453, Mikatahara-Cho, Kita-Ku, Hamamatsu, Shizuoka, 433-8558, Japan.
Suzuki E; Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, 3453, Mikatahara-Cho, Kita-Ku, Hamamatsu, Shizuoka, 433-8558, Japan.
Yoshii N; Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, 3453, Mikatahara-Cho, Kita-Ku, Hamamatsu, Shizuoka, 433-8558, Japan.
Niwa H; Division of Thoracic Surgery, Respiratory Disease Center, Seirei Mikatahara General Hospital, 3453, Mikatahara-Cho, Kita-Ku, Hamamatsu, Shizuoka, 433-8558, Japan.; Pokaż więcej
Źródło :: General thoracic and cardiovascular surgery [Gen Thorac Cardiovasc Surg] 2020 Oct; Vol. 68 (10), pp. 1156-1162. Date of Electronic Publication: 2020 Apr 09.
Typ publikacji :: Journal Article
MeSH Terms :: Induction Chemotherapy*
Anticoagulants/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*surgery
Heparin/*therapeutic use
Lung Neoplasms/*surgery
Venous Thromboembolism/*etiology
Adult ; Aged ; Carcinoma, Non-Small-Cell Lung/complications ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Female ; Humans ; Incidence ; Lung Neoplasms/complications ; Lung Neoplasms/drug therapy ; Male ; Middle Aged ; Neoplasm Recurrence, Local/complications ; Retrospective Studies ; Risk Factors ; Venous Thromboembolism/prevention & control ; Venous Thrombosis/prevention & control
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
Autorzy :: Orf K; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Rogosic S; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Dexter D; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Ancliff P; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Badle S; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Brierley J; Paediatric Bioethics Centre, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Cheng D; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Dalton C; Department of Pharmacy, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Dixon G; Department of Microbiology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Du Pré P; Department of Paediatric Intensive Care, Great Ormond Street Hospital for Children NHS Trustv, London, UK.
Grandjean L; Department of Infectious Diseases, Great Ormond Street Hospital for Children NHS Trust, London, UK.; UCL Great Ormond Street Institute of Child Health, London, UK.
Ghorashian S; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Mittal P; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
O'Connor D; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.; UCL Cancer Institute, London, UK.
Pavasovic V; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Rao A; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Samarasinghe S; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Vora A; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Bamford A; Department of Infectious Diseases, Great Ormond Street Hospital for Children NHS Trust, London, UK.; UCL Great Ormond Street Institute of Child Health, London, UK.
Bartram J; Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.; UCL Great Ormond Street Institute of Child Health, London, UK.; Pokaż więcej
Źródło :: British journal of haematology [Br J Haematol] 2020 Sep; Vol. 190 (5), pp. e274-e276. Date of Electronic Publication: 2020 Aug 23.
Typ publikacji :: Case Reports; Letter
MeSH Terms :: Coronavirus Infections*/diagnosis
Coronavirus Infections*/drug therapy
Coronavirus Infections*/etiology
Induction Chemotherapy*
Pandemics*
Pneumonia, Viral*/diagnosis
Pneumonia, Viral*/drug therapy
Pneumonia, Viral*/etiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/virology
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
Betacoronavirus/*metabolism
Adenosine Monophosphate/administration & dosage ; Alanine/administration & dosage ; COVID-19 ; Child, Preschool ; Humans ; Male ; SARS-CoV-2
: Raport

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.
Autorzy :: Kimura SI; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. .
Fujita H; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan.
Handa H; Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
Hosono N; Department of Hematology and Oncology, University of Fukui, Fukui, Japan.
Minamiguchi H; Department of Gastroenterology and Hematology, Shiga University of Medical Science, Shiga, Japan.
Takahashi T; Department of Oncology/Hematology, Shimane University Hospital, Izumo, Japan.
Kato H; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan.
Ono T; Division of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.
Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Matsumura I; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Miyazaki Y; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Pokaż więcej
Corporate Authors :: Japan Adult Leukemia Study Group (JALSG)
Źródło :: International journal of hematology [Int J Hematol] 2020 Sep; Vol. 112 (3), pp. 409-417. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji :: Journal Article
MeSH Terms :: Antimicrobial Stewardship*
Induction Chemotherapy*
Anti-Bacterial Agents/*administration & dosage
Antibiotic Prophylaxis/*statistics & numerical data
Infection Control/*methods
Leukemia/*drug therapy
Acute Disease ; Antifungal Agents/administration & dosage ; Drug Utilization ; Female ; Fluoroquinolones/administration & dosage ; Humans ; Infections/diagnosis ; Japan ; Male ; Surveys and Questionnaires ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
Autorzy :: Janoray G; Centre Hospitalier Régional et Universitaire, Henry Kaplan Center, Clinique D'Oncologie et de Radiothérapie, Tours, France; Université François Rabelais de Tours, France; EA 7505, 'Education Ethique Santé', EES, Tours, France. Electronic address: .
Pointreau Y; Centre Hospitalier Régional et Universitaire, Henry Kaplan Center, Clinique D'Oncologie et de Radiothérapie, Tours, France.
Alfonsi M; Clinique Sainte Catherine, Avignon, France.
Sire C; Centre Hospitalier de Lorient, Lorient, France.
Geoffrois L; Institut de Cancérologie de Lorraine, Vandoeuvre Lès Nancy, France.
de Raucourt D; Centre François Baclesse, Caen, France.
Bardet E; Centre René Gauducheau, Nantes, France.
Calais MH; Centre Hospitalier Régional et Universitaire, Henry Kaplan Center, Clinique D'Oncologie et de Radiothérapie, Tours, France.
Garaud P; Centre Hospitalier Régional et Universitaire, Henry Kaplan Center, Clinique D'Oncologie et de Radiothérapie, Tours, France.
Calais G; Centre Hospitalier Régional et Universitaire, Henry Kaplan Center, Clinique D'Oncologie et de Radiothérapie, Tours, France; Université François Rabelais de Tours, France.; Pokaż więcej
Źródło :: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Jul; Vol. 133, pp. 86-93. Date of Electronic Publication: 2020 May 23.
Typ publikacji :: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Induction Chemotherapy*/methods
Carcinoma, Squamous Cell/*therapy
Cetuximab/*administration & dosage
Chemoradiotherapy, Adjuvant/*methods
Cisplatin/*administration & dosage
Hypopharyngeal Neoplasms/*therapy
Laryngeal Neoplasms/*therapy
Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Drug Administration Schedule ; Female ; Follow-Up Studies ; France/epidemiology ; Humans ; Hypopharyngeal Neoplasms/mortality ; Hypopharyngeal Neoplasms/pathology ; Laryngeal Neoplasms/mortality ; Laryngeal Neoplasms/pathology ; Male ; Middle Aged ; Organ Sparing Treatments/methods ; Time Factors ; Treatment Outcome ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy.
Autorzy :: Talati C; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States. Electronic address: .
Goldberg AD; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Przespolewski A; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
Chan O; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.
Ali NA; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.
Kim J; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States.
Famulare C; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Sallman D; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.
Padron E; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.
Kuykendall A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.
Lancet JE; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.
Wang E; Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
Tallman MS; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Komrokji R; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.
Sweet K; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.; Pokaż więcej
Źródło :: Leukemia research [Leuk Res] 2020 Jun; Vol. 93, pp. 106367. Date of Electronic Publication: 2020 May 01.
Typ publikacji :: Comparative Study; Journal Article; Multicenter Study
MeSH Terms :: Induction Chemotherapy*
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/mortality
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Drug Resistance, Neoplasm/*drug effects
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Survival Rate
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: [Induction Chemotherapy with Gemcitabine and Cisplatin followed by Radiochemotherapy in locally advanced Nasopharyngeal Carcinoma].
Autorzy :: Luttke M; Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, München, Deutschland. .
Späth R; Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, München, Deutschland.
Marschner S; Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, München, Deutschland.
Walter F; Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistraße 15, 81377, München, Deutschland.; Pokaż więcej
Transliterated Title :: Induktionschemotherapie mit Cisplatin und Gemcitabin, gefolgt von Radiochemotherapie bei Nasopharynxkarzinomen.
Źródło :: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2020 Aug; Vol. 196 (8), pp. 740-742.
Typ publikacji :: Journal Article
MeSH Terms :: Induction Chemotherapy*
Nasopharyngeal Neoplasms*
Chemoradiotherapy ; Cisplatin/therapeutic use ; Deoxycytidine/analogs & derivatives ; Humans ; Nasopharyngeal Carcinoma/drug therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: [Influence of Combination with 1q21 Amplification or-No in Patients with Newly Diagnosed MM on the Clinical Effecacy of Bortezomib-based induction chemotherapy and Long-Term Prognosis of Patients].
Autorzy :: Gu WW; Department of Oncology, People's Hospital of Jinan City, Jinan, 271100, Shandong Province, China.
Wang JS; Department of Oncology, People's Hospital of Jinan City, Jinan, 271100, Shandong Province, China.
Mu K; Department of Oncology, People's Hospital of Jinan City, Jinan, 271100, Shandong Province, China.
Ren G; Department of Oncology, People's Hospital of Jinan City, Jinan, 271100, Shandong Province, China,E-mail: .; Pokaż więcej
Źródło :: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2020 Aug; Vol. 28 (4), pp. 1251-1255.
Typ publikacji :: Journal Article
MeSH Terms :: Induction Chemotherapy*
Multiple Myeloma/*drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Bortezomib/therapeutic use ; Disease-Free Survival ; Humans ; Prognosis ; Retrospective Studies ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
Autorzy :: Wu S; Department of Radiation Oncology.
Quan R; Department of Radiation Oncology.
Han L; Department of Otorhinolaryngology, the Second Clinical Medical College of Jinan University, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People's Hospital.
Zhang H; Department of Endocrinology, Hospital of Southern University of Science and Technology.
Zhang B; Department of Oncology, People's Hospital of Shenzhen Baoan District, the Affiliated Baoan Hospital of Shenzhen, Southern Medical University, Shenzhen, China.
Xu G; Department of Radiation Oncology.
Li X; Department of Radiation Oncology.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Jul 24; Vol. 99 (30), pp. e21325.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Chemoradiotherapy/*adverse effects
Induction Chemotherapy/*adverse effects
Nasopharyngeal Carcinoma/*radiotherapy
Nasopharyngeal Neoplasms/*pathology
Radiotherapy, Intensity-Modulated/*methods
Chemoradiotherapy/methods ; Female ; Follow-Up Studies ; Humans ; Induction Chemotherapy/methods ; Male ; Nasopharyngeal Carcinoma/mortality ; Neoplasm Metastasis/pathology ; Neoplasm Staging/methods ; Progression-Free Survival ; Recurrence ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III study.
Autorzy :: Baron F; GIGA-I3 and CHU, University of Liège, Liège, Belgium.
Efficace F; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.
Cannella L; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.
Muus P; Radboud University Medical Center, Nijmegen, Netherlands.
Trisolini S; Sapienza University, Rome, Italy.
Halkes CJM; Leiden University Medical Center, Leiden, Netherlands.
Fazi P; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.
Vignetti M; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.
Marie JP; Saint-Antoine Hospital, Paris, France.
Chiusolo P; Gemelli Hospital, Rome, Italy.
van der Velden W; Radboud University Medical Center, Nijmegen, Netherlands.
La Sala E; Gruppo Italiano Malattie Ematologiche Dell'Adulto GIMEMA, Rome, Italy.
Vitolo U; Candiolo Cancer Institute-IRCCS, Torino, Italy.
Thomas X; Lyon-Sud University Hospital, Lyon, France.
Lefrère F; Assistance Publique-Hôpitaux de Paris, Necker Children's Hospital, Paris, France.
Di Raimondo F; Universita di Catania, Catania, Italy.
Bourhis JH; Gustave Roussy cancer campus Grand Paris, Villejuif, France.
Specchia G; Giovanni XXIII- University Hospital, Bari, Italy.
Guimarães JE; Hospital S. João, Porto, Portugal.
Allione B; Candiolo Cancer Institute-IRCCS, Torino, Italy.
Vrhovac R; University Hospital Centre Zagreb, Zagreb, Croatia.
Ferrara F; Cardarelli Hospital, Naples, Italy.
Stevens-Kroef M; Radboud University Medical Center, Nijmegen, Netherlands.
Meert L; EORTC Headquarters, Brussels, Belgium.
de Witte T; Radboud University Medical Center, Nijmegen, Netherlands.
Willemze R; Leiden University Medical Center, Leiden, Netherlands.
Amadori S; University Tor Vergata, Rome, Italy.
Suciu S; EORTC Headquarters, Brussels, Belgium.; Pokaż więcej
Źródło :: American journal of hematology [Am J Hematol] 2020 Jul; Vol. 95 (7), pp. 749-758. Date of Electronic Publication: 2020 Apr 17.
Typ publikacji :: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :: Hematopoietic Stem Cell Transplantation*
Induction Chemotherapy*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Leukemia, Myeloid, Acute/*mortality
Leukemia, Myeloid, Acute/*therapy
Adolescent ; Adult ; Age Factors ; Allografts ; Cytarabine/administration & dosage ; Cytarabine/adverse effects ; Daunorubicin/administration & dosage ; Daunorubicin/adverse effects ; Etoposide/administration & dosage ; Etoposide/adverse effects ; Female ; Follow-Up Studies ; Humans ; Idarubicin/administration & dosage ; Idarubicin/adverse effects ; Male ; Middle Aged ; Mitoxantrone/administration & dosage ; Mitoxantrone/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Should the emphasis be on induction or consolidation therapy in transplant-eligible, newly diagnosed multiple myeloma?
Autorzy :: Krishnan A
Sonneveld P; Pokaż więcej
Źródło :: The Lancet. Haematology [Lancet Haematol] 2020 Jun; Vol. 7 (6), pp. e445-e446.
Typ publikacji :: Journal Article
MeSH Terms :: Consolidation Chemotherapy*
Induction Chemotherapy*
Stem Cell Transplantation*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*therapy
Humans ; Multiple Myeloma/diagnosis ; Multiple Myeloma/drug therapy ; Transplantation, Autologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Autorzy :: Li XY; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Qian JJ; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Yang M; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Zhang Y; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Wang SS; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Meng HT; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Yu WJ; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Tong HY; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Ye XJ; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Jin J; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.
Zhu HH; Department of Hematology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, Zhejiang, China.; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China.; Pokaż więcej
Źródło :: British journal of haematology [Br J Haematol] 2020 Jun; Vol. 189 (6), pp. e231-e234. Date of Electronic Publication: 2020 Apr 21.
Typ publikacji :: Letter; Research Support, Non-U.S. Gov't
MeSH Terms :: Consolidation Chemotherapy*
Induction Chemotherapy*
Philadelphia Chromosome*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
Administration, Oral ; Adolescent ; Adult ; Aged ; Dasatinib/administration & dosage ; Female ; Humans ; Imatinib Mesylate/administration & dosage ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Prednisone/administration & dosage ; Retrospective Studies
: Raport

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Induction Chemotherapy"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język